Cellectis S.A. (CLLS) vs Fate Therapeutics, Inc. (FATE)
Detailed comparison between Cellectis S.A., Fate Therapeutics, Inc..Total Return (%)
Cellectis S.A. (CLLS)Fate Therapeutics, Inc. (FATE)
Which stock do you think will perform better?
Cellectis S.A.
CLLS
Fate Therapeutics, Inc.
FATE
| Metric | Cellectis S.A. (CLLS) | Fate Therapeutics, Inc. (FATE) |
|---|---|---|
| Current Price | $1.46 | $0.98 |
| Change | 0.08 (5.79%) | 0.02 (2.01%) |
| Market Cap | $0.20B | $0.11B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -1.92 | -0.58 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $3.04 | $5.92 |
| 52-Week Low | $1.10 | $0.66 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-0.67 | $-1.64 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| CLLS | 2.09% | -3.32% | -51.98% | -92.48% | -95.39% | -95.47% |
| FATE | -6.73% | -21.66% | -76.35% | -96.69% | -85.62% | -85.60% |